Skip to main content

CLOVER HEALTH INVESTMENTS, CORP.

corporate_fare Company Profile

CLOVER HEALTH INVESTMENTS, CORP.

CLOV·NASDAQ·Finance·CIK 0001801170

Clover Health aims to empower physicians with technology to identify, manage, and treat chronic diseases earlier, leading to earlier diagnosis and treatment, earlier disease management, and more affordable and accessible care. The company's strategy involves improving care for its Medicare Advantage ("MA") members, developing extensive physician networks, and providing technology to support physicians. Its proprietary software platform, Clover Assistant, also licensed externally as Counterpart Assistant, supports real-time clinical decision-making at the point of care by providing clinicians with data and insights. This cloud-based software platform curates data from over 100 sources, offering physicians access to data-driven insights and personalized care recommendations for patients. Provider use of Clover Assistant enables data-driven clinical decision-making, benefiting members and driving rapid software iteration. The more providers use Clover Assistant, the more it learns and refines the precision of personalized data-driven recommendations. Clover Health combines beneficiary data with provider-generated data, using this feedback loop to continuously fine-tune its proprietary clinical rules and machine learning models, and to prioritize future software capabilities.

CLOVER HEALTH INVESTMENTS, CORP. (NASDAQ:CLOV) is a publicly traded company in the Finance sector. Wiseek monitors CLOV SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Clover Health Secures 4.5-Star Medicare Rating for 97% of Members After Court Order
  • Clover Health Details AI-Driven Cost Savings & Profitability Path in Q1 Supplemental Q&A
  • Former CFO Peter Kuipers Files Intent to Sell $3.06M in Shares
  • Clover Health Achieves First-Ever Positive GAAP Net Income in Q1, Reports $749M Revenue
  • Clover Health Reports First-Ever Positive GAAP Net Income, Strong Revenue Growth, and Significant Operating Cash Flow Turnaround

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.92B
Net Income
-$85.55M
Op. Cash Flow
-$66.93M
Free Cash Flow
-$68.98M
Operating Income
-$85.53M
Cash & Equivalents
$78.3M
Debt / Equity
0.00×
Net Margin
-4.4%
Shares Outstanding
511.97M sh
Source: 10-K · filed 2026-02-27 · accession 0001801170-26-000057
Browse all tickers starting with C →
$4.81 +0.01% today
52-week range · as of 2026-06-10 $1.58 – $4.44
Market cap
$2.53B
Volume
7.3M (0.8× avg)
3-mo avg 9.3M
Live data · 2026-06-18 09:12 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed CLOV - Latest Insights

CLOV
Jun 10, 2026, 8:31 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.24
Real-time Price: $4.81 info
Change: +$0.570 (+13%) info
Market Cap: $2.528B info
CLOV
May 18, 2026, 8:32 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.38
Real-time Price: $4.81 info
Change: +$1.43 (+42%) info
Market Cap: $2.528B info
CLOV
May 14, 2026, 3:20 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $3.48
Real-time Price: $4.81 info
Change: +$1.33 (+38%) info
Market Cap: $2.528B info
CLOV
May 08, 2026, 8:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.79
Real-time Price: $4.81 info
Change: +$2.02 (+72%) info
Market Cap: $2.528B info
CLOV
May 08, 2026, 8:06 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.81
Real-time Price: $4.81 info
Change: +$2.00 (+71%) info
Market Cap: $2.528B info
CLOV
May 06, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.70
Real-time Price: $4.81 info
Change: +$2.11 (+78%) info
Market Cap: $2.528B info
CLOV
Apr 28, 2026, 4:06 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $2.61
Real-time Price: $4.81 info
Change: +$2.20 (+84%) info
Market Cap: $2.528B info
CLOV
Apr 01, 2026, 8:32 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.73
Real-time Price: $4.81 info
Change: +$3.08 (+178%) info
Market Cap: $2.528B info
CLOV
Mar 19, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.88
Real-time Price: $4.81 info
Change: +$2.93 (+156%) info
Market Cap: $2.528B info
CLOV
Mar 10, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.00
Real-time Price: $4.81 info
Change: +$2.81 (+140%) info
Market Cap: $2.528B info
CLOV
Mar 10, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.99
Real-time Price: $4.81 info
Change: +$2.82 (+142%) info
Market Cap: $2.528B info
CLOV
Mar 06, 2026, 9:06 AM EST
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $2.05
Real-time Price: $4.81 info
Change: +$2.76 (+135%) info
Market Cap: $2.528B info
CLOV
Feb 27, 2026, 8:08 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $2.09
Real-time Price: $4.81 info
Change: +$2.72 (+130%) info
Market Cap: $2.528B info
CLOV
Feb 26, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.22
Real-time Price: $4.81 info
Change: +$2.59 (+117%) info
Market Cap: $2.528B info
CLOV
Jan 14, 2026, 8:32 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.54
Real-time Price: $4.81 info
Change: +$2.27 (+89%) info
Market Cap: $2.528B info
CLOV
Jan 09, 2026, 4:08 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $2.60
Real-time Price: $4.81 info
Change: +$2.21 (+85%) info
Market Cap: $2.528B info